Pharmaceuticals Made in South Africa (PHARMISA) is an industry association of local pharmaceutical manufacturers. The organization is made up of local South African producers and Black Empowerment companies. Our singular interest is to promote local production, create empowerment opportunities and boost local capacity whilst some of the other trade associations have some interest in this, there are others, that primarily represent importers and it would not have been possible to achieve this should the PHARMISA members have been part of the one of the other trade associations that presently exist in South Africa. We required an organisation that had express focus on promoting local manufacture
PHARMISA has focused on three priorities; these included preferential procurement, the development of productive incentives to boost local manufacture and addressing tariff and non-tariff barriers to entry. Our focus has been on the first two areas and once these are bedded down we will place more attention on the third.
South African Government, together with its social partners, has placed significant effort and investment in repositioning the South African economy into one that is less import dependent and one which can gradually improve its export orientation. PHARMISA has been able to successfully position itself in this social partnership and future economic positioning. To this end pharmaceuticals have been positioned as one of the key priority sectors for industrialisation and technology development, in the South African governments industrial policy action plan.
One of the key issues that local industry has strongly advocated, with South African Government is the need to balance the trading playing fields. In many cases the playing fields are lopsided in favour of importers, as they are subsidised by the export destination. The South African market an extremely open one and one which is highly vulnerable to import substitution and displacement.
Contact
Aspen Pharmacare
Building 7, Healthcare Park, Woodlands Drive, Woodmead, Sandton, 2196
Tel: +27 (0) 11 706 4471
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental…
The CEO of Pharma Dynamics explains why the company was the perfect match for Lupin, as the fastest growing, and largest independently owned acquirable pharmaceutical business in South Africa, why…
The chairman of PHARMISA reveals how pharmaceuticals has been designated as one of eight priority sectors of South African Government’s Industrial Policy Action Plan (IPAP), how South African life expectancy…
The CEO of Pierre Fabre for South Africa reveals how his focus has been on marketing the company brand locally, why the goal of the company is to develop business…
The EO of SAMED discusses recent regulations surrounding the medical device industry in South Africa, why South Africa remains the hub and the major gateway to Africa for medical devices…
The managing director of UTi Pharma reveals how UTi is no longer just an international forwarding company but covers a broad spectrum of activities; why as global business increases it…
The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical…
The country manager for BMS South Africa talks about the company’s first to market strategy, and how BMS has shifted the treatment paradigm for oncology in South Africa. Through our platform, we introduce the…
Iain Barton reveals how the acquisition of RTT Medical by IHS in 2013 has allowed Imperial to become the biggest pharma supply chain and general logistics services player on the African…
Peter Fuller provides us with an update on the integration of Covidien businesses, and explains how Medtronic is bringing innovation to South African patients and contributing to the improvement of the…
Adv. Leslie Sedibe, CEO of Proudly South African explains how the Proudly South African campaign aims to promote local products and services to ultimately address unemployment, and what his main…
The country president of Novartis South Africa reveals how Novartis has recently moved to new premises, demonstrating a clear commitment to continue investing in the country; why South Africa…
The managing director at Adcock Ingram Critical Care reveals the company’s unique business model. As a long-established division within Adcock Ingram, Critical Care operates with relative independence. What is the relationship…
See our Cookie Privacy Policy Here
